Login
Home / 000520.KS : KSC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Samil Pharmaceutical Co.,Ltd

₩7010 -$2830.00 (-28.76%)
KSC · 15 Sep 2026 06:30 UTC
Previous Close
₩7050
Day Range
₩6710₩7090
Year Range
₩5500₩12860
Market Cap
149.81B
AVG Volume
159.87K
Trailing/Forward PE
-3.97/-
PEG ratio
0.1
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Korea ExchangeKR
Revenue (KRW)
020B40B60B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (KRW)
-15B-10B-5B05B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (KRW)
-15B-10B-5B05B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (KRW)
-40B-20B020B40B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (KRW)
-15B-10B-5B05B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (KRW)
-600-400-200020024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (KRW)
010B20B30BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (KRW)
050B100B150B200BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-20020406024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%10%20%30%40%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
-10%-7.5%-5%-2.5%0%2.5%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
010M20M30M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (KRW)
0255075100Dec 12Dec 13Dec 14Dec 15Dec 16Dec 17Dec 18Dec 19Dec 20Dec 21
Book Value Per Share (KRW)
05000100001500024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (KRW)
0100B200B300B400B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
02505007501000med 89.07Jan 21Apr 21Aug 21Aug 23Dec 23Mar 24Jun 24
Free Cash Flow Yield
-8%-6%-4%-2%0%med -4.38%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
0.60.811.21.4med 0.97Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EV/EBITDA
050100150med 32.72Jul 24Oct 24Jan 25May 25Aug 25Dec 25Mar 26
Price/Operating Cashflow
0100200300med 24.16Jun 23Apr 24Jul 24Nov 24Feb 25Jun 25Sep 26
Price to Book
0.811.21.41.61.8med 1.32Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Samil Pharmaceutical Co.,Ltd
000520.KS
Stockpicker

Video analysis: 000520.KS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.